148 related articles for article (PubMed ID: 37405221)
1. Spinal Instability as a Prognostic Factor in Patients With Spinal Metastasis of Castration-resistant Prostate Cancer.
Miyaji Y; Nakanishi K; Yamamoto A; Yoden E; Tokiya R; Okawaki M; Inubushi M; Katsui K
Cancer Diagn Progn; 2023; 3(4):449-456. PubMed ID: 37405221
[TBL] [Abstract][Full Text] [Related]
2. Predictive Value of the Spinal Instability Neoplastic Score for Survival and Ambulatory Function After Surgery for Metastatic Spinal Cord Compression in 110 Patients with Prostate Cancer.
Wänman J; Jernberg J; Gustafsson P; Abul-Kasim K; Grabowski P; Bobinski L; Crnalic S
Spine (Phila Pa 1976); 2021 Apr; 46(8):550-558. PubMed ID: 33273445
[TBL] [Abstract][Full Text] [Related]
3. Reliability of the spinal instability neoplastic scale among radiologists: an assessment of instability secondary to spinal metastases.
Fisher CG; Versteeg AL; Schouten R; Boriani S; Varga PP; Rhines LD; Heran MK; Kawahara N; Fourney D; Reynolds JJ; Fehlings MG; Gokaslan ZL
AJR Am J Roentgenol; 2014 Oct; 203(4):869-74. PubMed ID: 25247954
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and Prognosis of Neurological Decompression and Stabilization for Spinal Metastasis: Is Assessment with the Spinal Instability Neoplastic Score Useful for Predicting Surgical Results?
Masuda K; Ebata K; Yasuhara Y; Enomoto A; Saito T
Asian Spine J; 2018 Oct; 12(5):846-853. PubMed ID: 30213167
[TBL] [Abstract][Full Text] [Related]
5. An analysis of tumor-related potential spinal column instability (Spine Instability Neoplastic Scores 7-12) eventually requiring surgery with a 1-year follow-up.
Vargas E; Lockney DT; Mummaneni PV; Haddad AF; Rivera J; Tan X; Jamieson A; Mahmoudieh Y; Berven S; Braunstein SE; Chou D
Neurosurg Focus; 2021 May; 50(5):E6. PubMed ID: 33932936
[TBL] [Abstract][Full Text] [Related]
6. Assessing the utility of the spinal instability neoplastic score (SINS) to predict fracture after conventional radiation therapy (RT) for spinal metastases.
Shi DD; Hertan LM; Lam TC; Skamene S; Chi JH; Groff M; Cho CH; Ferrone ML; Harris M; Chen YH; Balboni TA
Pract Radiat Oncol; 2018; 8(5):e285-e294. PubMed ID: 29703703
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Introducing the Spinal Instability Neoplastic Score in Routine Clinical Practice for Patients With Spinal Metastases.
Versteeg AL; van der Velden JM; Verkooijen HM; van Vulpen M; Oner FC; Fisher CG; Verlaan JJ
Oncologist; 2016 Jan; 21(1):95-101. PubMed ID: 26668252
[TBL] [Abstract][Full Text] [Related]
8. Prediction of skeletal-related events in patients with non-small cell lung cancer.
Aiba H; Kimura T; Yamagami T; Watanabe N; Sakurai H; Kimura H; Shimozaki S; Yamada S; Otsuka T
Support Care Cancer; 2016 Aug; 24(8):3361-7. PubMed ID: 26980332
[TBL] [Abstract][Full Text] [Related]
9. The clinical utility of the Spinal Instability Neoplastic Score (SINS) system in spinal epidural metastases: a retrospective study.
Dakson A; Leck E; Brandman DM; Christie SD
Spinal Cord; 2020 Aug; 58(8):892-899. PubMed ID: 32047252
[TBL] [Abstract][Full Text] [Related]
10. Predictors for progression of metastatic prostate cancer to castration-resistant prostate cancer in Indians.
Sureka SK; Maheshwari R; Agnihotri S; Mitash N; Ahmad S; Mandhani A
Indian J Med Res; 2016 May; 143(Supplement):S68-S73. PubMed ID: 27748280
[TBL] [Abstract][Full Text] [Related]
11. Outcomes for Vertebrectomy for Malignancy and Correlation to the Spine Instability Neoplastic Score (SINS): a 10-Year Single-Center Perspective.
Donnellan CJ; Roser S; Maharaj MM; Davies BN; Ferch R; Hansen MA
World Neurosurg; 2020 Jun; 138():e151-e159. PubMed ID: 32081818
[TBL] [Abstract][Full Text] [Related]
12. The Spine Instability Neoplastic Score: an independent reliability and reproducibility analysis.
Campos M; Urrutia J; Zamora T; Román J; Canessa V; Borghero Y; Palma A; Molina M
Spine J; 2014 Aug; 14(8):1466-9. PubMed ID: 24275615
[TBL] [Abstract][Full Text] [Related]
13. Bone Scan Index predicts outcome in patients with metastatic hormone-sensitive prostate cancer.
Poulsen MH; Rasmussen J; Edenbrandt L; Høilund-Carlsen PF; Gerke O; Johansen A; Lund L
BJU Int; 2016 May; 117(5):748-53. PubMed ID: 25906907
[TBL] [Abstract][Full Text] [Related]
14. SINS Score and Stability: Evaluating the Need for Stabilization Within the Uncertain Category.
Pennington Z; Ahmed AK; Westbroek EM; Cottrill E; Lubelski D; Goodwin ML; Sciubba DM
World Neurosurg; 2019 Aug; 128():e1034-e1047. PubMed ID: 31103761
[TBL] [Abstract][Full Text] [Related]
15. Shifting paradigms in the estimation of survival for castration-resistant prostate cancer: A tertiary academic center experience.
Afshar M; Evison F; James ND; Patel P
Urol Oncol; 2015 Aug; 33(8):338.e1-7. PubMed ID: 26059077
[TBL] [Abstract][Full Text] [Related]
16. Prospective Evaluation of the Relationship Between Mechanical Stability and Response to Palliative Radiotherapy for Symptomatic Spinal Metastases.
van der Velden JM; Versteeg AL; Verkooijen HM; Fisher CG; Chow E; Oner FC; van Vulpen M; Weir L; Verlaan JJ
Oncologist; 2017 Aug; 22(8):972-978. PubMed ID: 28469043
[TBL] [Abstract][Full Text] [Related]
17. The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer.
Oka T; Hatano K; Okuda Y; Yamamoto A; Uemura T; Yamamichi G; Tomiyama E; Ishizuya Y; Yamamoto Y; Kato T; Kawashima A; Fujita K; Nonomura N
Int J Clin Oncol; 2023 Mar; 28(3):427-435. PubMed ID: 36580184
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of High-Sensitivity Modified Glasgow Prognostic Score in Castration-Resistant Prostate Cancer Patients Who Received Docetaxel.
Ando K; Sakamoto S; Saito S; Maimaiti M; Imamura Y; Sazuka T; Sato N; Komiya A; Anzai N; Ichikawa T
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673284
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of curative effect and prognosis analysis of patients with spinal metastases treated by percutaneous vertebroplasty combined with postoperative radiotherapy and radiotherapy alone].
Cao XY; Liu YS; Lei MX; Liu SB; Zhou SG; Cao YC; Jiang WG
Zhonghua Yi Xue Za Zhi; 2016 Dec; 96(47):3805-3810. PubMed ID: 28057095
[No Abstract] [Full Text] [Related]
20. Earlier use of androgen receptor-axis-targeted drugs may improve overall survival in patients with non-metastatic castration-resistant prostate cancer.
Mori K; Kimura T; Ito K; Onuma H; Tanaka M; Matsuura T; Kurokawa G; Iwatani K; Inaba Y; Sakanaka K; Sasaki H; Miki J; Shimomura T; Miki K; Egawa S
Prostate; 2018 Jul; 78(10):766-772. PubMed ID: 29635810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
